The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris
Sign Up to like & getrecommendations! Published in 2019 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02198-19
Abstract: The in vitro and in vivo activity of the arylamidine T-2307 against Candida auris was evaluated. T-2307 demonstrated in vitro activity (MIC ranges ≤ 0.008 to 0.015 μg/ml at 50% inhibition; 0.125 to >4 μg/ml at 100% inhibition). ABSTRACT… read more here.
Keywords: arylamidine 2307; vivo activity; candida auris; activity ... See more keywords
The Arylamidine T-2307 as a Novel Treatment for the Prevention and Eradication of Candida tropicalis Biofilms
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232416042
Abstract: Candida tropicalis is an emerging pathogen with a high mortality rate due to its virulence factors, including biofilm formation, that has important repercussions on the public health system. The ability of C. tropicalis to form… read more here.
Keywords: candida tropicalis; treatment; eradication; arylamidine 2307 ... See more keywords